Cited by 185Systemic Lupus Erythematosus ResearchReproductive System and PregnancyPregnancy and preeclampsia studies

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome

Bramham, K., Hunt, BJ, Germain, S., Calatayud, I., Khamashta, M., Bewley, S., Nelson-Piercy, C.·2010·Lupus

DOI 10.1177/0961203309347794

Open this paper in CoChat — free account

Abstract

Women with antiphospholipid syndrome (APS) may have diverse pregnancy outcomes. The objective of this study was to evaluate pregnancy outcome in women with APS according to their clinical phenotype, i.e. thrombotic and obstetric APS. Eighty-three pregnancies in 67 women with APS were included in the study, including 21 with recurrent miscarriage (Group 1), 21 with late fetal loss or early delivery due to placental dysfunction (Group 2) and 41 with thrombotic APS (Group 3). Group 3 had higher rates of preterm delivery (26.8% versus 4.7%, p = 0.05) than Group 1 and more small for gestational age (SGA) babies than Group 2 (39.5% versus 4.8%, p = 0.003). Group 2 had significantly longer gestations compared with their pretreatment pregnancies (38.4 [28.4-41.4] versus 24.0 [18-35] weeks, p < 0.0001) and 100% live birth rate after treatment with aspirin and low-molecular-weight heparin (LMWH). In conclusion, women with thrombotic APS (Group 3) have higher rates of pregnancy complications than those with obstetric APS (Groups 1 and 2). Treatment with aspirin and LMWH is associated with improved outcomes for women with previous late fetal loss or early delivery due to placental dysfunction (Group 2).

Integrity signals

Registry

Crossref · 10.1177/0961203309347794

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)
Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
The Antiphospholipid Syndrome
Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,524
The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
Brown, M. A., Lindheimer, M. D., de SWIET, M., et al. (2001) · Hypertension in Pregnancy · doi:10.3109/10641950109152635 · Cited by 1,369
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Antiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Henderson-Smart, D. J., Meher, S., & King, J. F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub2 · Cited by 1,016
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · CHEST Journal · doi:10.1378/chest.08-0761 · Cited by 790
Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
Cowchock, F. S., Reece, E. A., Balaban, D. J., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 585
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
Empson, M. B., Lassere, M., Craig, J. C., & Scott, J. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002859.pub2 · Cited by 486
Untitled work
(1992) · PubMed · Cited by 434

Show all 40 references

Research works printed but not linked: 11

Loizou S., 1988, Q J Med, 68, 525
Branch DW, 1992, Obstet Gynecol, 80, 614
Ruffatti A., 1997, Clin Exp Rheumatol, 15, 499
Rosove MH, 1990, Obstet Gynecol, 75, 630
Lima F., 1996, Clin Exp Rheumatol, 14, 131
Gestation Network Centile Calculator
Huong DL, 2001, J Rheumatol, 28, 2025
Branch DW, 2003, Obstet Gynecol, 101, 1333
Duley L., 2007, Cochrane Database Syst Rev, CD004659
Sullivan A., 2001, Contemp Obstet Gynecol, 46, 100
Empson M., 2005, Cochrane Database Syst Rev, CD002859

Sorted by citations

EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,318
Self-citation
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Self-citation
Antiphospholipid syndrome
Schreiber, K. I., Sciascia, S., de Groot, P. G., Devreese, K. M. J., Jacobsen, S., Ruiz‐Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.103 · Cited by 445
Self-citation
Management of the obstetric antiphospholipid syndrome
Derksen, R. H. W. M., Khamashta, M. A., & Branch, D. W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20105 · Cited by 200
Self-citation
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies
Sciascia, S., Hunt, B. J., Talavera-García, E., Lliso-Ribera, G., Khamashta, M. A., & Cuadrado, M. J. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.09.078 · Cited by 201
Self-citation
Recurrent implantation failure: A comprehensive summary from etiology to treatment
Ma, J., Gao, W., & Li, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1061766 · Cited by 212
14th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome
de Jesús, G. R., Agmon‐Levin, N., de Andrade, C. A. F., Andréoli, L., Chighizola, C. B., Porter, T. F., Salmon, J. E., Silver, R. M., Tincani, A., & Branch, D. W. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.02.003 · Cited by 187
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study
Mekinian, A., Lazzaroni, M. G., Kuzenko, A., Alijotas-Reig, J., Ruffatti, A., Levy, P., Canti, V., Bremme, K., Bezanahary, H., Bertero, T., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.01.012 · Cited by 182
The implications of autoimmunity and pregnancy
Borchers, A. T., Naguwa, S. M., Keen, C. L., & Gershwin, M. E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.015 · Cited by 179
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss
Bramham, K., Thomas, M., Nelson-Piercy, C., Khamashta, M., & Hunt, B. J. (2011) · Blood · doi:10.1182/blood-2011-02-339234 · Cited by 180
Self-citation
Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis
Bramham, K., Hunt, B. J., Bewley, S., Germain, S., Calatayud, I. L., Khamashta, M. A., & Nelson‐Piercy, C. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100997 · Cited by 165
Self-citation
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
Schreiber, K. I., Breen, K. A., Cohen, H., Jacobsen, S., Middeldorp, S., Pavord, S. R., Regan, L., Roccatello, D., Robinson, S. E., Sciascia, S., et al. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1603359 · Cited by 128
Self-citation
Pathogenesis and management of antiphospholipid syndrome
Arachchillage, D. J., & Laffan, M. (2017) · British Journal of Haematology · doi:10.1111/bjh.14632 · Cited by 125
The antiphospholipid syndrome: from pathophysiology to treatment
Negrini, S. M., Pappalardo, F., Murdaca, G., Indiveri, F., & Puppo, F. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0430-5 · Cited by 117
Antiphospholipid Syndrome during pregnancy: the state of the art.
Prima, F. A. F. D., Valenti, O., Hyseni, E., Giorgio, E., Faraci, M., Renda, E., Domenico, R. D., & Monte, S. (2011) · PubMed Central · Cited by 111
Current treatment of antiphospholipid syndrome: lights and shadows
Espinosa, G., & Cervera, R. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.88 · Cited by 110
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity: A European multicentre retrospective study
Salvan, E., Ross, T. D., Gerosa, M., Andreoli, L., Maina, A., Alijotas-Reig, J., Carolis, S. D., Mekinian, A., Bertero, M. T., Canti, V., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0191 · Cited by 108
Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andréoli, L., Limper, M., Tincani, A., & Ward, M. M. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000924 · Cited by 101
Managing antiphospholipid syndrome in pregnancy
Schreiber, K. I., & Hunt, B. J. (2019) · Thrombosis Research · doi:10.1016/s0049-3848(19)30366-4 · Cited by 96
Self-citation
Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis
Walter, I. J., Haneveld, M. J. K., Lely, A. T., Bloemenkamp, K. W. M., Limper, M., & Kooiman, J. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102901 · Cited by 93
Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study
Tonello, M., Hoxha, A., Sciascia, S., Cuadrado, M. J., Latino, J. O., Udry, S., Reshetnyak, T. M., Costedoat-Chalumeau, N., Morel, N., Marozio, L., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1632388 · Cited by 89
Self-citation
Immunologic causes and thrombophilia in recurrent pregnancy loss
Alecsandru, D., Klimczak, A. M., García-Velasco, J. A., Pirtea, P., & Franasiak, J. M. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.01.017 · Cited by 97
Antiphospholipid syndrome – an update
Linnemann, B. (2018) · VASA · doi:10.1024/0301-1526/a000723 · Cited by 86
High-risk pregnancy and the rheumatologist
Soh, M. C., & Nelson‐Piercy, C. (2014) · Rheumatology · doi:10.1093/rheumatology/keu394 · Cited by 84
Self-citation
Fetal outcome in autoimmune diseases
Carvalheiras, G., Faria, R., Braga, J. S., & Vasconcelos, C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.12.002 · Cited by 79
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
Giacomelli, R., Afeltra, A., Bartoloni, E., Berardicurti, O., Bombardieri, M., Bortoluzzi, A., Carubbi, F., Caso, F., Cervera, R., Ciccia, F., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102738 · Cited by 78
Pregnancy and autoimmune connective tissue diseases
Marder, W., Littlejohn, E., & Somers, E. C. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.05.002 · Cited by 79
Antiphospholipid syndrome: An update on risk factors for pregnancy outcome
Carolis, S. D., Tabacco, S., Rizzo, F., Giannini, A., Botta, A., Salvi, S., Garufi, C., Panici, P. B., & Lanzone, A. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.03.018 · Cited by 76
Antiphospohlipid syndrome in obstetrics
Danza, Ã., Ruiz‐Irastorza, G., & Khamashta, M. A. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.10.006 · Cited by 74
Self-citation
Management of rheumatologic diseases in pregnancy
Ateka–Barrutia, O., & Nelson‐Piercy, C. (2012) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.12.54 · Cited by 73
Self-citation
Lupus and pregnancy: integrating clues from the bench and bedside
Ruiz‐Irastorza, G., & Khamashta, M. A. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02443.x · Cited by 74
Self-citation
Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?
MEKINIAN, A., Costedoat-Chalumeau, N., MASSEAU, A., Tincani, A., Caroli, S. D., Alijotas‐Reig, J., Ruffatti, A., Ambrožič, A., Botta, A., Guern, V. L., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.040 · Cited by 74
Pregnancy and renal outcomes in lupus nephritis: an update and guide to management
Bramham, K., Soh, M. C., & Nelson‐Piercy, C. (2012) · Lupus · doi:10.1177/0961203312456893 · Cited by 69
Self-citation
Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
Žigon, P., Pirkmajer, K. P., Tomšič, M., Kveder, T., Božič, B., Šemrl, S. S., Čučnik, S., & Ambrožič, A. (2015) · Journal of Immunology Research · doi:10.1155/2015/975704 · Cited by 68
The treatment of anti-phospholipid syndrome: A comprehensive clinical approach
Chighizola, C. B., Andréoli, L., Gerosa, M., Tincani, A., Ruffatti, A., & Meroni, P. L. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.02.003 · Cited by 66
Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder
D’Ippolito, S., Meroni, P. L., Koike, T., Veglia, M., Scambia, G., & Simone, N. D. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.004 · Cited by 64
Thrombosis in pregnancy and maternal outcomes
James, A. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21106 · Cited by 60
Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study
Fischer-Betz, R., Specker, C., Brinks, R., & Schneider, M. (2012) · Lupus · doi:10.1177/0961203312451335 · Cited by 56
Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study
Ruffatti, A., Favarò, M., Hoxha, A., Zambon, A., Marson, P., Ross, T. D., Calligaro, A., Tonello, M., & Nardelli, G. B. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.03.004 · Cited by 55
Current insights in obstetric antiphospholipid syndrome
Schreiber, K. I., Radin, M., & Sciascia, S. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000406 · Cited by 53
Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome
Gustavsen, A., Skattum, L., Bergseth, G., Lorentzen, B., Fløisand, Y., Bosnes, V., Mollnes, T. E., & Barratt‐Due, A. (2017) · Medicine · doi:10.1097/md.0000000000006338 · Cited by 52
Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome
Arachchillage, D. J., Laffan, M., & Pericleous, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021331 · Cited by 55
Pregnancy Morbidity in Antiphospholipid Syndrome: What Is the Impact of Treatment?
de Jesús, G. R., Rodrigues, G., de Jesús, N. R., & Levy, R. A. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-013-0403-6 · Cited by 47
The challenge of pregnancy for patients with SLE
Ateka–Barrutia, O., & Khamashta, M. A. (2013) · Lupus · doi:10.1177/0961203313504637 · Cited by 44
Self-citation
Grossesse et syndrome des antiphospholipides
Costedoat-Chalumeau, N., Guettrot-Imbert, G., Guern, V. L., Leroux, G., Huong, D. U. L. T., Wechsler, B., Morel, N., Vauthier-Brouzes, D., Dommergues, M., Cornet, A., et al. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.01.003 · Cited by 45
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)
Erton, Z. B., Sevim, E., de Jesús, G. R., Cervera, R., Ji, L., Pengo, V., Ugarte, A., ANDRADE, D. C. O. D., Andréoli, L., Atsumi, T., et al. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000633 · Cited by 42
Preimplantation genetic testing for aneuploidy in unexplained recurrent pregnancy loss: a systematic review and meta-analysis
Mümüşoğlu, S., Telek, S. B., & Ata, B. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.08.326 · Cited by 41
Genetic risk factors in thrombotic primary antiphospholipid syndrome: A systematic review with bioinformatic analyses
Islam, M. A., Khandker, S. S., Alam, F., Kamal, M. A., & Gan, S. H. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.10.014 · Cited by 42
Obstetrical Antiphospholipid Syndrome: From the Pathogenesis to the Clinical and Therapeutic Implications
Marchetti, T., Cohen, M., & de Moerloose, P. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/159124 · Cited by 40
The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome
Gerde, M., Ibarra, E. E. M., Kenzie, R. M., Suarez, C. F., Heer, C., Álvarez, R., Iglesias, M., Balparda, J., Beruti, E., & Rubinstein, F. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.08.004 · Cited by 41
Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence
Clark, C. A., Laskin, C. A., & Spitzer, K. A. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms020 · Cited by 37
Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome
Bontadi, A., Ruffatti, A., Marson, P., Tison, T., Tonello, M., Hoxha, A., Silvestro, G. D., & Punzi, L. (2012) · Journal of Clinical Apheresis · doi:10.1002/jca.21229 · Cited by 36
Management of Obstetric Antiphospholipid Syndrome
de Jesús, G. R., dos Santos, F. C., Oliveira, C., Mendes‐Silva, W., de Jesús, N. R., & Levy, R. A. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0218-2 · Cited by 35
Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes
Soh, M. C., Pasupathy, D., Gray, G., & Nelson‐Piercy, C. (2013) · Rheumatology · doi:10.1093/rheumatology/ket173 · Cited by 35
Self-citation
Pregnancy outcomes in patients with systemic autoimmunity
Canti, V., Castiglioni, M. T., Rosa, S., Franchini, S., Sabbadini, M. G., Manfredi, A. A., & Rovere, P. Q. (2011) · Autoimmunity · doi:10.3109/08916934.2011.593600 · Cited by 33
Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome
Wijetilleka, S., Scoble, T., & Khamashta, M. A. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328354ae8c · Cited by 33
Self-citation
Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss
Bowman, Z. S., Wünsche, V., Porter, T. F., Silver, R. M., & Branch, D. W. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.09.052 · Cited by 33
Treatment of antiphospholipid syndrome
Radin, M., Cecchi, I., Rubini, E., Foddai, S. G., Barinotti, A., Menegatti, E., Roccatello, D., & Sciascia, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108597 · Cited by 32
Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome
Yelnik, C., Lambert, M., Drumez, É., Guern, V. L., Bacri, J.-L., Guerra, M. M., Laskin, C. A., Branch, D. W., Sammaritano, L. R., Morel, N., et al. (2018) · Lupus · doi:10.1177/0961203318787032 · Cited by 33
Update on Antiphospholipid Syndrome: Ten Topics in 2017
Cavazzana, I., Andréoli, L., Limper, M. A., Franceschini, F., & Tincani, A. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0718-4 · Cited by 29
Myeloproliferative Disorders in Pregnancy
Harrison, C. N., & Robinson, S. E. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.01.008 · Cited by 27
Anti‐phospholipid antibodies and reproductive failures
Beltagy, A., Trespìdi, L., Gerosa, M., Ossola, M. W., Meroni, P. L., & Chighizola, C. B. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13258 · Cited by 28
Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms
Lapoirie, J., Contis, A., Guy, A., Lifermann, F., Viallard, J., Sentilhes, L., James, C., & Duffau, P. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1484097 · Cited by 26
Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome
Chighizola, C. B., Gerosa, M., Trespìdi, L., Giacomo, A. D., Rossi, F., Acaia, B., & Meroni, P. L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.968129 · Cited by 26
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies
Ruffatti, A., Tonello, M., Favarò, M., Ross, T. D., Calligaro, A., Gervasi, M. T., Gervasi, M. T., & Hoxha, A. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.10.001 · Cited by 25
Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome—A Retrospective Analysis and a Review of Additional Treatment in Pregnancy
Mayer-Pickel, K. I., Eberhard, K., Lang, U., & Cervar-Zivkovic, M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8569-0 · Cited by 25
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women
Belhocine, M., Coutte, L., Silva, N. M., Morel, N., Guettrot-Imbert, G., Paule, R., Jeunne, C. L., Fredi, M., Dreyfus, M., Pietté, J. C., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1745-2 · Cited by 24
Neonatal outcome in pregnant patients with antiphospholipid syndrome
Jeremić, K., Stefanović, A., Dotlić, J., Stojnić, J., Kadija, S., Vilendečić, Z., Janjic, T., & Jeremić, J. (2014) · Journal of Perinatal Medicine · doi:10.1515/jpm-2014-0118 · Cited by 23
Pregnancy and contraception in systemic and cutaneous lupus erythematosus
Guettrot-Imbert, G., Morel, N., Guern, V. L., Plu‐Bureau, G., Francès, C., & Costedoat-Chalumeau, N. (2016) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2015.07.015 · Cited by 22
Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile
Högdén, A., Antovič, A., Berg, E., Bremme, K. A., & Chaireti, R. (2019) · Lupus · doi:10.1177/0961203319852155 · Cited by 22
Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review
Ruffatti, A., Hoxha, A., Favarò, M., Tonello, M., Colpo, A., Cucchini, U., Banzato, A., & Pengo, V. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8571-6 · Cited by 21
Management of pregnant women with antiphospholipid antibodies
Ruffatti, A., Favarò, M., Calligaro, A., Zambon, A., & Ross, T. D. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1565995 · Cited by 21
Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
Lee, E. E., Jun, J. K., & Lee, E. B. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e24 · Cited by 20
Treatment of the antiphospholipid syndrome
Galli, M. (2013) · Autoimmunity Highlights · doi:10.1007/s13317-013-0056-5 · Cited by 38
Diretrizes para o tratamento da síndrome do anticorpo antifosfolipídeo
Danowski, A., Rêgo, J., Kakehasi, A. M., Funke, A., de Carvalho, J. F., Lima, I., de Souza, A. W. S., & Levy, R. A. (2013) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042013000200005 · Cited by 21
Guidelines for the treatment of antiphospholipid syndrome
Danowski, A., Rêgo, J., Kakehasi, A. M., Funke, A., de Carvalho, J. F., Lima, I., de Souza, A. W. S., & Levy, R. A. (2013) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/s2255-5021(13)70021-x · Cited by 19
Diagnosis and management of antiphospholipid syndrome
Heuser, C. C., & Branch, W. D. (2018) · doi:10.1002/9781119072980.ch31 · Cited by 20
Interplay of immune components and their association with recurrent pregnancy loss
Tasadduq, R., Ajmal, L., Batool, F., Zafar, T., Babar, A., Riasat, A., & Shakoori, A. R. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.01.013 · Cited by 20
Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block
Ruffatti, A., Favarò, M., Brucato, A. L., Ramoni, V. L., Facchinetti, M., Tonello, M., Ross, T. D., Calligaro, A., Hoxha, A., Grava, C., et al. (2015) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2015.11.006 · Cited by 19
Prenatal-onset neurodevelopmental disorders secondary to toxins, nutritional deficiencies, and maternal illness
Graf, W. D., Kekatpure, M. V., & Kosofsky, B. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00014-2 · Cited by 19
Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature
Hoxha, A., Tormene, D., Campello, E., & Simioni, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849692 · Cited by 17
Maternal and fetal complications of systemic lupus erythematosus
Cauldwell, M., & Nelson‐Piercy, C. (2012) · The Obstetrician & Gynaecologist · doi:10.1111/j.1744-4667.2012.00113.x · Cited by 17
Self-citation
Epidemiologie, Risikofaktoren und Risikostratifizierung venöser Thromboembolien (VTE) in Schwangerschaft und Wochenbett
Tsikouras, P. N., Tempelhoff, G.-F. V., & Rath, W. H. (2017) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/s-0043-107618 · Cited by 16
Management of haematological malignancy in pregnancy
El‐Hemaidi, I., & Robinson, S. E. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.10.007 · Cited by 14
Pregnancy Management in Women with Antiphospholidic Syndrome
Radu, A., Dudu, S. C., Ciobanu, A. M., Peltecu, G. C., Iancu, G., Botezatu, R., Gică, N., & Panaitescu, A. M. (2019) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2019.14.2.148 · Cited by 15
The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: A systematic review and meta-analysis
Tian, Y., Xu, J., Chen, D., Yang, C., & Peng, B. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2021.102121 · Cited by 13
Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications—a population-based study
Rhein, A. K., Rabinovich, A., Abuhasira, R., Lubaton-Barshishat, S., & Erez, O. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102430 · Cited by 12
Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome
Schreiber, K. I., Aguilera, S., Amengual, O., Cohen, H., ANDRADE, D. C. O. D., Duarte‐García, A., Gerosa, M., Nelson‐Piercy, C., Radin, M., Raio, L., et al. (2025) · The Lancet Rheumatology · doi:10.1016/s2665-9913(24)00396-5 · Cited by 12
Self-citation
Maternal and Fetal Outcomes in Systemic Lupus Erythematosus Pregnancies
Poh, Y. J., Yii, I. Y. L., Goh, L. H., Li, H. H., Yang, L., Tan, H. K., Thumboo, J., & Tan, L. K. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2020373 · Cited by 14
Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients
Larosa, M., Guern, V. L., Morel, N., Belhocine, M., Ruffatti, A., Silva, N. M., Paule, R., Mouthon, L., Dreyfus, M., Pietté, J. C., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02518-7 · Cited by 12
Diagnosis and management of antiphospholipid syndrome in pregnancy
Myers, B., & Pavord, S. R. (2011) · The Obstetrician & Gynaecologist · doi:10.1576/toag.13.1.15.27636 · Cited by 11
El embarazo en las enfermedades autoinmunes sistémicas: mitos, certezas y dudas
Danza, Ã., Ruiz‐Irastorza, G., & Khamashta, M. A. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2016.03.019 · Cited by 11
Self-citation
Antiphospholipid syndrome in pregnancy
Soh, M. C., & Nelson‐Piercy, C. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.10.57 · Cited by 11
Self-citation
Rheumatische Erkrankungen in der Schwangerschaft
Fischer‐Betz, R. (2012) · Der Internist · doi:10.1007/s00108-012-3029-2 · Cited by 10
Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents
Gwozdz, A. M., Doyle, A. J., Hunt, B. J., Tincknell, L., Jackson, N., Saha, P., Breen, K. A., Smith, A., Cohen, A. T., & Black, S. A. (2020) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2020.09.013 · Cited by 10
Self-citation
Lupus systémique et syndrome des antiphospholipides : comment prendre en charge la grossesse ?
Guettrot-Imbert, G., Guern, V. L., Morel, N., Vauthier-Brouzes, D., Tsatsaris, V., Pannier, E., Pietté, J. C., & Costedoat-Chalumeau, N. (2015) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2014.12.005 · Cited by 10
Risk-based secondary prevention of obstetric antiphospholipid syndrome
Ruffatti, A., Calligaro, A., Ross, T. D., Favarò, M., Tonello, M., Banzato, A., Punzi, L., & Pengo, V. (2012) · Lupus · doi:10.1177/0961203312446388 · Cited by 9
High-Risk Pregnancy
Wildschut, H. I. J., Duvekot, J. J., Cook, J. R., Bacchus, L. J., Bewley, S., Creighton, S., Dear, J., Williams, D., Kilby, M. D., Crouch, N. S., et al. (2017) · Cambridge University Press eBooks · doi:10.1017/9781108349185 · Cited by 11
Self-citation
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy
Edens, C. (2021) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2021.09.016 · Cited by 7
Schwangerschaft und Nierenerkrankungen
Siekierka-Harreis, M., & Rump, L. C. (2011) · Der Internist · doi:10.1007/s00108-011-2824-5 · Cited by 7

Authors: Bramham, K., Hunt, B., Germain, S., Calatayud, I., Khamashta, M., Bewley, S., & Nelson-Piercy, C.
Affiliations: Guy's Hospital (GB)
Department of Maternal Medicine, Women's services directorate and Lupus Unit, Guy's & St Thomas' NHS Foundation Trust, London, UK
Department of Maternal Medicine, Women's services directorate and Lupus Unit, Guy's & St Thomas' NHS Foundation Trust, London, UK,
ORCID: Bramham, K.
Khamashta, M.
Bewley, S.
Venue: Lupus
Publisher: SAGE Publications
Published: 2009-11-06
Volume: 19
Issue: 1
Pages: 58-64
ISSN: 0961-2033 (ISSN-L)
1477-0962
DOI: 10.1177/0961203309347794
OpenAlex: W2043383287
Cited by: 185
References: 40
Citations by year: 2026: 5 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 14 · 2020: 9 · 2019: 12 · 2018: 15 · 2017: 11 · 2016: 13 · 2015: 12 · 2014: 17 · 2013: 13 · 2012: 15
FWCI: 9.64
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Lupus (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: National Institute for Health and Care Research (DRF-2009-02-18)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords: antiphospholipid syndrome, pregnancy outcomes, clinical phenotype, thrombotic antiphospholipid syndrome, obstetric antiphospholipid syndrome, recurrent pregnancy loss, placental insufficiency, preterm birth, small for gestational age, aspirin, low molecular weight heparin
MeSH terms: Adult, Aspirin, Female, Heparin, Low-Molecular-Weight, Humans, Infant, Newborn, Infant, Small for Gestational Age, Obstetric Labor, Premature, Phenotype, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Retrospective Studies, Antiphospholipid Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks